GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 52 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,000 | +33.3% | 1,667 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | +200.0% | 1,667 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 1,667 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 1,667 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 1,667 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 1,667 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | -33.3% | 1,667 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | -25.0% | 1,667 | 0.0% | 0.00% | – |
| Q2 2015 | $4,000 | -20.0% | 1,667 | 0.0% | 0.00% | – |
| Q1 2015 | $5,000 | 0.0% | 1,667 | 0.0% | 0.00% | – |
| Q4 2014 | $5,000 | -37.5% | 1,667 | 0.0% | 0.00% | – |
| Q3 2014 | $8,000 | -65.2% | 1,667 | 0.0% | 0.00% | – |
| Q2 2014 | $23,000 | -8.0% | 1,667 | 0.0% | 0.00% | – |
| Q1 2014 | $25,000 | +92.3% | 1,667 | 0.0% | 0.00% | – |
| Q4 2013 | $13,000 | -18.8% | 1,667 | 0.0% | 0.00% | – |
| Q3 2013 | $16,000 | +100.0% | 1,667 | 0.0% | 0.00% | – |
| Q2 2013 | $8,000 | – | 1,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $248,617 | 0.07% |
| Geneos Wealth Management Inc. | 417,350 | $801,312 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $23,040 | 0.02% |
| RETIREMENT GUYS FORMULA LLC | 11,500 | $22,080 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $36,981 | 0.01% |
| OSAIC HOLDINGS, INC. | 3,275,192 | $6,288,345 | 0.01% |
| Traynor Capital Management, Inc. | 34,707 | $66,638 | 0.01% |
| Atria Wealth Solutions, Inc. | 259,800 | $498,816 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $9,569 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $353,016 | 0.01% |